De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature

In acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), treatment with the P2Y<sub>12</sub> inhibitors ticagrelor or prasugrel is recommended over clopidogrel due to a better efficacy, albeit having more bleeding complication. These higher bleeding...

Full description

Bibliographic Details
Main Authors: Daniel MF Claassens, Dirk Sibbing
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
P2Y<sub>12</sub> inhibitor
clopidogrel
ticagrelor
prasugrel
de-escalation
platelet function testing
Online Access:https://www.mdpi.com/2077-0383/9/9/2983

Internet

https://www.mdpi.com/2077-0383/9/9/2983

Similar Items